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Aims: To define regions of loss on the distal portion of chromosome 12q in gastric adenocarcinoma.
Methods: Microsatellite analysis on chromosome 12 was performed on 19 human gastric cancer cell
lines using 77 markers, 71 of which were within or distal to 12q21; some portions of this region
showed extended regions of homozygosity (ERHs) in 10 of 19 gastric cancer cell lines. In addition,
microdissected tumour cells from 76 primary gastric adenocarcinomas were examined using 13 mark-
ers of interest implicated by the cell line data; 70% of these showed allelic imbalance (AI) at one or
more markers in or distal to 12q21.
Results: Mapping ERHs in the cell lines and sites of AI in the tumours identified three regions that con-
tain putative tumour suppressor genes: region A is located within 2.8 Mb between markers D12S1667
and D12S88; region B, within 1.9 Mb between markers D12S1607 and D12S78; and region C, in
0.74 Mb between markers D12S342 and D12S324. Fluorescence in situ hybridisation (FISH) analysis
in two cell lines confirmed that two of the ERHs reflected deletions, not amplifications, of D12S81 in
region A and D12S340 in region C. FISH analysis of marker D12S1075 within an ERH containing
region B in one cell line showed neither amplification nor deletion. AI on 12q was not associated with
prognosis, but was associated with ethnicity of the patient.
Conclusions: These results identify regions on chromosome 12 that appear to contain tumour suppres-
sor genes important in the development of gastric cancer.
Cancer develops as a multistep process that includesinactivation of tumour suppressor genes, each of whichacts as a brake on cell proliferation, and amplification of
oncogenes, which promote cell growth. Microsatellite analysis
has been particularly helpful in revealing sites of tumour sup-
pressor genes, through loss of heterozygosity (LOH) studies,
using markers with high percentages of heterozygosity. When
one allele of a tumour suppressor gene is mutated, the other
normal allele frequently becomes lost, often accompanied by
duplication of the mutant allele, in addition to surrounding
markers, thus generating a homozygous state for markers in
the region of the tumour suppressor gene. In the study of pri-
mary tumours, LOH is frequently incomplete because of the
presence of contaminating normal cells; therefore allelic
imbalance (AI) is a more accurate term. AI can also occur if
one allele is highly amplified.
“Several studies of gastric adenocarcinoma reported
deletions of portions of chromosome 12, but these
regions were not well defined, because small numbers of
markers were used”
In the study of gastric cancer, the investigation of regions of
AI has been a useful approach for the identification of areas of
DNA containing tumour suppressor genes (reviewed in
Tahara, 19981). Several studies of gastric adenocarcinoma
reported deletions of portions of chromosome 12, but these
regions were not well defined, because small numbers of
markers were used.2–5 Additional evidence for the loss of part
of chromosome 12, especially 12q, has been obtained from
comparative genomic hybridisation (CGH) studies (fig 1).6–8
These studies reported losses on the distal end of chromosome
12 of 40–43% of gastric adenocarcinomas examined. We
sought to prepare, using a large number of markers, a detailed
map of regions of AI on the distal portion of chromosome 12q
to identify regions of loss in gastric cancers.
In addition to the study of primary tumours, another
approach for analysis is to examine gastric cancer cell lines for
extended regions of homozygosity (ERHs). Because the
microsatellite markers we used were highly polymorphic
(with an observed average rate of heterozygosity of 66%), it is
statistically unlikely that a series of adjacent markers would
all be homozygous by chance. For example, in a series of five
consecutive markers, each of which had a 66% probability of
appearing in a heterozygous state in any individual, the
probability of all five appearing in a homozygous state is
(1 − 0.66)5, or 0.0045. Consequently, the appearance of such
ERHs in a cell line is unlikely to be explained by chance and
more likely to occur as a result of the same mechanism
described for LOH: loss of a portion of DNA flanking a tumour
suppressor gene. Thus, microsatellite analysis of gastric cancer
cell lines can be a very useful adjunct to the study of primary
tumours, for detecting regions of DNA that may contain
tumour suppressor genes. We have combined this approach
with the analysis of AI of primary tumours for the study of the
distal end of the long arm of chromosome 12 in gastric cancer.
MATERIALS AND METHODS
Cell lines
The gastric adenocarcinoma cell lines used were: YCC-1,
YCC-2, YCC-3, YCC-5, YCC-6, YCC-7, YCC-10, YCC-11,9
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MKN-28, MKN-74, MKN-75,10 SNU-1, SNU-5, SNU-16, N87,
KATO-III,11 AGS, RF-1, and Hs746T. The last four cell lines
were obtained from the American Type Culture Collection
(Rockville, Maryland, USA). Cell lines N87, SNU-1, SNU-5,
and SNU-16 were provided by Dr H Oie (National Cancer
Institute, Bethesda, USA), and cell lines MKN-28, MKN-74,
and MKN-75 were provided by Dr R Lotan (M D Anderson
Cancer Center, Houston, USA). Cell lines were maintained in
Dulbecco’s minimal essential medium (DMEM), with high
glucose (Hs746T), DMEM/F12 (MKN-28, MKN-74, and
MKN-75), RPMI-1640 (SNU-1, SNU-5, SNU-16, and N87),
Ham’s F12 (AGS), Iscove’s medium (KATO-III), Liebowitz’s
L-15 medium (RF-1), or Eagle’s minimal essential medium
(all YCC cell lines). All media were purchased from Life Tech-
nologies (Bethesda, Maryland, USA), and were supplemented
with 10% fetal bovine serum, except for KATO-III, which was
supplemented with 20% fetal bovine serum. Media were sup-
plemented with penicillin (50 units/ml)/streptomycin (50 µg/
ml) or antibiotic/antimycotic according to the manufacturer’s
specifications (Life Technologies). Trypsinised cell pellets
(2 × 105 cells) were digested overnight in 40 µl of a proteinase
K solution (1 mg/ml, in 50mM Tris/HCl buffer, pH 8.0, with
1mM EDTA and 0.45% Tween 20) at 52°C overnight. Digested
materials were heated to 95°C for 15 minutes to denature the
proteinase K. This material was used as a template for the
polymerase chain reaction (PCR) without additional purifica-
tion.
Tumours
Formalin fixed, paraffin wax embedded gastrectomy speci-
mens from 76 cases of gastric adenocarcinoma were obtained
from hospitals in New Orleans, Louisiana, USA (n = 35), San
Antonio, Texas, USA (n = 33), and Rochester, Minnesota, USA
(n = 8). The ethnicity, age, and sex of the patients and
anatomical sites of the tumours were obtained from medical
records or tumour registries. Ethnic groups represented were
non-Hispanic white (n = 38), Hispanic (mainly of Mexican
descent; n = 18), and African–American (n = 19). The ethnic
origin of one patient was unknown. All specimens and patient
information were acquired with approval of the institutional
review boards of the University of Texas Health Sciences Center
at San Antonio or Louisiana State University Health Sciences
Center. Survival data were available for 66 patients from Loui-
siana and Texas. Staging was performed using standard TNM
criteria.12 Tumours were graded and classified as intestinal, dif-
fuse, or mixed subtype by an experienced surgical pathologist
(JCB) according to the criteria of Laurén.13 Tumours were
included in our study only if they could be microdissected,
either manually or with laser capture microdissection (LCM)
with the Pixcell II or IIe microscope (Arcturus Engineering,
Mountain View, California, USA) such that the preparations
would include at least 70% tumour nuclei.14 The series of cases
omitted diffuse tumours with a low density of tumour cells,
and tumours in which profuse inflammatory cells were
intimately associated with the tumour cells. According to
convention,15 tumours known to display high frequency micro-
satellite instability, using the Bethesda panel of five markers
(BAT25, BAT26, D2S123, D5S346, and D17S250), were omitted
from our study, but tumours with low frequency microsatellite
instability were included. The details of the analysis for micro-
satellite instability were reported previously.16
Of the 76 tumours, 69 were microdissected using LCM;
seven tumours were manually microdissected. Sections (6 µm
thick) were cut in a manner designed to avoid cross contami-
nation from other patients’ specimens during microtomy3;
slides were prepared as described previously, for either manual
or LCM harvested materials.16 Tumour and benign cells were
harvested by LCM using a 30 µm laser spot with 50–60 mWatt
power. Cell preparations of 1000–2000 pulses were harvested
and digested in 40 µl of a proteinase K solution (as described
above for the cell lines) at 52°C overnight. Digested materials
were heated at 95°C for 15 minutes to denature the proteinase
K. This material was used as a template for PCR without addi-
tional purification.
Polymerase chain reaction
DNA templates were amplified with primers for the microsat-
ellite markers listed in fig 2.17 Annealing temperatures were
optimised for each primer pair, and details of PCR conditions
are available upon request (bschne@lsuhsc.edu). DNA tem-
plates were amplified as described previously,3 except that the
cycle number was increased to 40. Control reactions consisted
of all components except template. PCR products were
separated on 7% polyacrylamide gels with 33% formamide
and 33% urea, and bands were visualised with autoradiogra-
phy without intensifying screens. In all primary tumours,
DNA bands amplified from tumours were compared with
those amplified from benign cells (always lymphocytes, except
for one case in which normal epithelium was used) from the
same patient, using approximately equivalent numbers of
laser pulses from tumour and normal tissue. AI was evaluated
by visual inspection, using as a standard a change in band
ratios of 50%, as described by MacGrogan et al.18 For the cell
lines, normal tissue from the same patient from whom the cell
line was derived was unavailable. Consequently, a statistical
argument was used to determine whether the length of a
region of homozygosity was considered significant. The prod-
uct of probabilities of homozygosity for consecutive markers
was calculated to determine the probability that the entire
region would be homozygous by chance. In practice, the ERHs
we identified, consisting of five adjacent markers, gave a prob-
ability no greater than 0.0069. Of the 77 markers examined, 71
were located in the region of 12q21 or distal to that. Marker
Figure 1 Comparative genomic hybridisation studies by van
Grieken and Kim6 8 show losses in the distal portion of chromosome
12q. In the study by van Grieken et al, 17 of 46 gastric cancers
showed deletions on the distal portion of 12q; in the study by Kim et
al, six of 15 gastric cancers showed such deletions. Figure 1 was
prepared from diagrams in published reports; however, because of
the limits of resolution of CGH, the precise breakpoints on 12q can-
not be determined with this technique.
142 Schneider, Rha, Chung, et al
www.molpath.com
order was determined mainly by the database at the
University of California at Santa Cruz (http://
genome.ucsc.edu/goldenPath). Numbers such as base position
83969109 refer to base positions on chromosome 12 in
the Santa Cruz website, using the November 2002 freeze of
the browser, except for marker D12S360, which was placed
using the June 2002 freeze. Two markers not listed in the
Santa Cruz website (D12S76 and D12S386) were positioned
according to data located in the National Center for
Bioinformatics website (http://www.ncbi.nlm.nih.gov/
genemap98/map.cgi?CHR=12).
Fluorescence in situ hybridisation
Metaphase chromosome spreads of cell lines KATO-III and
MKN-28 were prepared on glass slides using a standard cyto-
genetic protocol.19 20 The centromere probe was chromosome
Figure 2 The diagram indicates the positions of markers and extended regions of homozygosity (ERH; shown in grey) in 19 gastric cancer
cell lines. 1, homozygous; 2, heterozygous. Del, marker was shown to be deleted in FISH experiments. Not del, equivalent numbers of
centromeres and non-centromeric probes were seen in FISH experiments. The markers in boldface were used for the analysis of the tumours
shown in fig 5.
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enumeration probe (CEP) 12 α satellite DNA, which
was labelled with Spectrum Orange (Vysis, Downers Grove,
Illinois, USA). Bacterial artificial chromosome (BAC) DNA
used to identify regions containing markers D12S1075 and
D12S81 had addresses RP11–150F20 and RP11–389G16,
respectively21; a P1 artificial chromosome (PAC) probe
containing marker D12S340 had address RPCI1–157K6. The
BAC and PAC DNAs were labelled by nick translation with
biotin-14-dATP (Life Technologies). Chromosome spreads
were denatured for two minutes in a 70% formamide/2×
saline sodium citrate (SSC), pH 7.0, solution. Hybridisation
solutions containing 40 ng of the labelled BAC or PAC DNA
and 0.5 µl of the CEP DNA in buffer (50% formamide, 10%
dextran sulfate, and 2× SSC, pH 7.0) were denatured for five
minutes and hybridised overnight in a humid chamber at
37°C, washed, and incubated in avidin conjugated fluorescein
isothiocyanate (FITC), at 1.5 mg/ml. Amplification was
performed with biotinylated anti-avidin and avidin–FITC.
Chromosomes were counterstained using DAPI II (4′,6-
diamidino-2-phenylindole; Vysis) and viewed using a
Zeiss Axioplan 2 fluorescent microscope equipped with
FITC, DAPI, Texas Red, and triple bandpass filter sets. Images
were captured using Applied Imaging Probevision software
and printed using a Mitsubishi CP800DW colour
printer.
Statistical analysis
The relation between AI at the three regions and categorical
variables of sex or ethnicity of the patient and anatomical site,
stage, TNM, and grade was established using either the χ2 test
or Fisher’s exact test. For continuous variables such as age,
ANOVA was used to ascertain the significance of the
association between those variables and AI at the three sites.
Time to event was used to calculate the relative hazard of
death given AI status. Kaplan Meier curves were constructed
using SPSS (SPSS, Chicago, Illinois, USA), and the Tarone-
Ware test was used to test for significance. A Cox proportional
hazards model was used to ascertain the significance of AI in
the presence of other covariates such as age and stage.
RESULTS
ERHs were identified by the examination of 19 gastric cancer
cell lines, using 77 microsatellite markers, 73 of which were on
12q, with 71 markers located at 12q21 or more distal.
Beginning at 12q21, markers were located on average 0.9 Mb
apart. Cell lines were scored as to whether one or two alleles
were visible, and results are summarised in fig 2. The micro-
satellite markers used in this analysis were mostly highly
polymorphic, averaging 66% observed rates of heterozygosity
(or 34% homozygosity), such that five consecutive markers
Figure 3 Laser capture
microdissection images. (A) The
stained and coverslipped section is
used for the identification of tumour
cells (haematoxylin and eosin stain).
(B) The next section to that shown in
(A) is dark because of the lack of a
coverslip (methyl green stain). (C)
Tumour cells are specifically removed.
(D) The tumour cells have been
captured to provide DNA as a
template for the polymerase chain
reaction.
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showing only one allele have an average probability of occur-
ring by chance of 0.0045 or less. Therefore, regions where five
or more consecutive markers showed only one allele were
likely to have been deleted from the chromosome. Ten of the
19 cell lines contained ERHs on 12q; three cell lines showed
ERHs over most of distal 12q. Most useful, however, were
smaller ERHs, such as those found in cell lines AGS, Hs746T,
and KATO-III.
The isolation of tumour cells and lymphocytes from 69 of
the 76 patients was performed with LCM (fig 3). This
technique allows the isolation of very pure populations of
tumour cells, so that the loss of one allele was sometimes
almost complete (fig 4A) Other examples of microsatellite
analysis in tumour–normal pairs are shown in fig 4B,C. DNA
from cell lines was amplified with all 77 markers, but not all
markers amplified well from templates retrieved from paraffin
wax blocks. From the analyses of the ERHs in the cell lines, 13
robustly amplifying markers were selected within or near
regions of interest.
Microsatellite analysis of 76 microdissected tumours and
matched lymphocyte control DNA was performed for the 13
markers, and results are summarised in fig 5. The percentage
of informative cases showing AI at each marker is listed on the
right side of fig 5, in addition to the numbers of tumours that
are informative at that marker and percentages of observed
heterozygosity. Eighteen tumours had AI at most of the mark-
ers examined, whereas 23 of the tumours had no losses at the
markers examined. From the remaining tumours, in cases
where abundant material was available, additional microsatel-
lite analyses were performed (fig 6).
From the analysis of tumour and cell line data, we identified
three regions—called A, B, and C—which probably contain
genes important in gastric cancer. Results from both tumours
and cell lines were useful in narrowing down the regions. For
example, in region A, data from cell lines implicates the region
between markers D12S1670 and D12S1598, which is homo-
zygous in eight of 17 cell lines, including three cell lines with
small deletions of four to 11 markers each. However, tumour
data suggest that the boundaries of the region of loss are
markers D12S1667 (base position 83969109 on chromosome
12 from the Santa Cruz website, November 2002 freeze) and
D12S88 (base position 86787581), a physical distance of
2.8 Mb. The ERH in region A in KATO-III covers only four
markers, with a probability of 0.0083 of occurring by chance.
Figure 4 (A) In laser capture microdissection harvested tumours, which have very little contamination by normal DNA, near complete absence
of one of the sets of bands may be seen in the tumours, as shown in the tumour lane in both cases. Marker, D12S1051. (B) Amplification of
DNA from normal (N) and tumour (T) cells at marker D12S105 in two normal/tumour pairs. In case 1, tumour DNA shows no difference from
normal DNA at this marker. In case 2, allelic imbalance is indicated because the lower set of bands is decreased in density. Faint reactions
were not scored. For example, if light bands were visible, but neither upper nor lower bands exceeded the density seen in the lower bands of
the tumour in case 2, that reaction would not be scored. (C) Two sets of bands of approximately equal density were amplified from the normal
DNA, whereas we sometimes observed a decrease in the density of one band from the tumour DNA, accompanied by intensification of the
density of the other band, consistent with a duplication of the portion of the chromosome containing the putative mutant gene. Marker,
D12S1128.
Figure 5 Seventy six tumours were subjected to microsatellite analysis using 13 markers within or near regions A, B, or C. These 13 markers
and their locations with respect to regions A, B, and C are identified in boldface in the chromosome diagram in fig 2. At the right side of the
figure are percentages of allelic imbalance (% AI), numbers of informative cases (#inf), and observed percentages of heterozygosity (%het).
Black squares, AI; open squares, heterozygous markers with no AI; grey squares, non-informative (homozygous); /, no data; *, microsatellite
instability.
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However, fluorescent in situ hybridisation (FISH) analysis
confirms that marker D12S81 is deleted in this cell line (fig
7A). In region A, we found the greatest percentage of AI (41%)
at D12S379, at base position 85247191 on 12q21.31.
Telomeric to region A, in 12q23, we noted three ERHs of 10
or more markers, in cell lines Hs746T, MKN-28, and SNU-16.
The data from the three cell lines suggest a smallest region of
overlap between D12S346 and D12S1030. However, this region
is not supported by tumour data. Elimination of cell line
SNU-16 from the analysis produces a pattern more consistent
with that seen in the tumours (fig 6; tumours 6, 18, 32, 17, 35,
15, 37, 11, and 13). Data from these tumours and from cell
lines Hs746T and MKN-28 define a region of 1.78 Mb, which
we call region B, extending between D12S1607 (base position
102141863) and D12S78 (base position 104042753), a physical
distance of 1.9 Mb. FISH analysis for D12S1075, which lies
within the ERH containing region B in cell line MKN-28, indi-
cated an equivalent number of centromeres and copies of the
marker (fig 7B). Such data are inconsistent with amplification
or with deletion alone, but not with deletion followed by
abnormal segregation.
In 12q24 in three cell lines (AGS, KATO-III, and YCC-5), there
are ERHs that define region C, lying between D12S342 (base
position 125525016) and D12S324 (base position 126266436),
covering a physical distance of 0.74 Mb. In the cell line
KATO-III, FISH analysis indicated that D12S340, which falls
within this region (at base position 125783088), was deleted
(fig 7C). This interpretation was also consistent with the
tumour data, although markers D12S342, D12S340, and
D12S324 did not amplify well from the templates retrieved from
paraffin wax. Note tumours 11, 24, and 30, which apparently
have deletions spanning this region, as shown in fig 6.
There were no significant univariate associations between
AI at the 12q markers examined and sex or age of the patient,
stage, grade, T, N, M designation, or morphological subtype of
the tumour. However, ethnicity was associated with AI on 12q
Figure 6 Some of the tumours showing partial losses from data
shown in fig 5 were subjected to additional analysis, where
available material permitted. Black squares, AI; open squares,
heterozygous markers with no AI; grey squares, non-informative
(homozygous); /, no data; *, microsatellite instability.
Table 1 Allelic imbalance (AI) on chromosome 12q
according to ethnicity
AI on any portion of chromosome 12q
Negative Positive p Value
Ethnicity (n=75)
White 16 22
Hispanic 4 14 0.045*
African-American 3 16
*Fisher’s exact test, when data are compressed into a 2×2 table of
white versus minority, compared for 12q status.
Table 2 Anatomical site of tumour compared with
allelic imbalance (AI) on chromosome 12q and
ethnicity
Cardia Body Antrum p Value
Ethnicity (n=49)
White 10 6 8 0.0019*
Hispanic 0 4 7
African–American 1 3 10
AI on 12q (n=50)
Absent 4 6 4 0.059†
Present 7 7 22
The anatomical site of origin of the tumour could be determined for
66% of the 76 tumours.
*Fisher’s exact test, when the table is collapsed into a 2×2 table
comparing white with minority for anatomical site (cardia versus
body+antrum). If the grouping is (cardia+body) versus antrum,
p=0.023. †Fisher’s exact test, when table is collapsed into a 2×2
table comparing (cardia+body) versus antrum for AI on chromosome
12q.
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(table 1). Tumours from patients from the minority ethnic
groups (Hispanics and African–Americans) were more likely
to show AI on 12q than were tumours from white patients
(p = 0.045; table 1). This may be related to the site of the
tumour because minority patients were more likely to have
tumours in the antrum (p = 0.0225), and there was a trend
for antral tumours to show AI at 12q (p = 0.059; table 2).
The median survival for those patients whose tumour DNA
demonstrated AI on 12q was 285 days, compared with 351
days for patients whose tumours had no AI on 12q. These
numbers are not significantly different.
As expected, AI at each of the three sites on 12q was signifi-
cantly associated with AI at the other two regions on chromo-
some 12q (p < 0.001 in each case); in addition, AI at the 12q
sites was also associated with AI at any of three markers
(D2S123, D5S546, or D17S250) on other chromosomes
performed in a previous analysis (p = 0.036).16
DISCUSSION
The combined analysis of ERHs in cell lines and AI in tumours
has been useful in refining regions that probably contain
tumour suppressor genes in other tumour types, such as
melanomas.22 Cell lines offer the advantage of providing virtu-
ally limitless amounts of high quality DNA, with no contami-
nation by normal cells. Tumour analysis provides confirmation
of the clinical relevance of results obtained with the artificial
cell line system, and may reveal interesting associations of
genetic alterations and clinical or pathological features of the
tumours.
Losses of distal portions of chromosome 12q in gastric can-
cers have been detected in several large comparative genomic
hybridisation (CGH) studies, at frequencies of 37–47%.6–8
Curiously, other CGH studies found very few or no 12q losses
in gastric cancers.23–30 Whether the difference in results relate
to the populations studied or to the limitations in sensitivity of
CGH studies is unclear.
In studies using higher resolution techniques, such as LOH
analyses, the involvement of losses on chromosome 12q in the
development of some gastric cancers has been reported. Fey et
al found that 55% of gastric cancers showed deletions using
probes for a region of 12q24–qter.2 Sano found 31% loss at a
single marker at 12q24.3–qter.4 In a different set of gastric
cancers, we previously reported 38% AI at marker D12S78
(n = 48).3 Schmutte et al reported LOH of 42% at a marker
internal to the thymine DNA glycosylase (TDG) gene on
12q22–q24.1.5 None of these studies used sufficient numbers
of markers to define the borders of regions of LOH or AI.
Using a larger set of markers, we have identified three
regions of loss on chromosome 12q in DNA from gastric can-
cer cell lines and gastric tumours. Some of these regions have
Figure 7 (A) Fluorescence in situ hybridisation (FISH) analysis of
the cell line KATO-III shows four copies of the chromosome 12
centromere (red) and three copies of sequence homologous to the
bacterial artificial chromosome (BAC), which contains marker
D12S81 (green), a marker contained in region A. An arrow
indicates the centromere of the copy of chromosome 12 in which the
marker has been deleted. (B) FISH analysis of cell line MKN-28
shows two copies of chromosome 12, indicated by the centromere
probe (red). The sequence homologous to a BAC containing marker
D12S1075 is present on both chromosomes 12 (green). D12S1075
is contained within an extended region of homozygosity that
encompasses both regions A and B. (C) FISH analysis of cell line
KATO-III indicates copies of the centromeric region of chromosome
12 stained red and copies of the DNA containing the marker
D12S340, contained in region C, stained green. The arrow
indicates the centromere of a copy of chromosome 12 in which the
marker has been deleted.
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been implicated in the development of other tumour types.
Regions A and B are near regions identified by Kimura et al as
being affected in pancreatic cancer.31 32 Using 40 pancreatic
tumours, 19 pancreatic cancer cell lines, and 24 markers on
chromosome 12q, Kimura et al reported two regions of loss:
one between D12S81 and D12S1719 (67.5%) and another
between D12S360 and D12S78 (60%). These overlap our
regions A, at 12q21.31 and B, at 12q23.3.
A candidate gene near region B is thymine DNA glycosylase
(TDG), found at base position 104240443, at 12q23.3. This
gene encodes a protein that initiates T : G mismatch repair by
excising the mismatched T.33 Schmutte et al found 42% LOH in
gastric cancers at a marker within intron 8 of the TDG gene.
No mutations were found in the TDG gene in gastric cancers.5
However, this study did not examine TDG expression or
promoter methylation, and so could not exclude some other
mechanism as a means of inactivation of a second allele. Yat-
suoka et al reported decreases in the degree of TDG mRNA
expression in pancreatic cancer cell lines.34
“A candidate gene near region B is thymine DNA glyco-
sylase, found at base position 104240443, at
12q23.3”
Region C is located near a putative gene frequently affected
in carcinoma ex pleomorphic adenomas, also called malignant
mixed tumours of the salivary gland. Marker D12S395 (base
position 119615138) showed LOH in 39% of these tumours.35
In a small group of paired adenomas and carcinomas, 50% of
both cell types showed LOH, suggesting that loss at this site
was an early event in tumour development.
When we combined Hispanic and African–American ethnic
groups and compared them with non-Hispanic whites, we
found an association of ethnicity with AI on chromosome 12q.
We speculate that this association arises from differences in
Helicobacter pylori infection patterns associated with socioeco-
nomic status in these minority populations. In a study of
Texan ethnic groups, Malaty et al found a higher incidence of
H pylori infection among Hispanics and African–Americans
than among whites.36 Helicobacter pylori infection is associated
with damage to the lower part of the stomach.37 Association
between ethnicity and tumour site has been reported in other
American populations also.38 In our study, the Hispanic and
black patients more frequently had tumours originating in the
antrum than did white patients, and there was a strong trend
for antral tumours to show AI at chromosome 12q.
Gastric cancer originating in the antrum and associated
with H pylori infection appears to be a different disease to can-
cer of the gastric cardia; therefore, it is not surprising that
these two tumour types might tend to have different genetic
alterations. Other authors have previously shown differences
between cardia and non-cardia gastric cancers in losses of
chromosomes 4q and 14q and in gains in chromosomes 2p, 7p,
17q, and 20q.30 39 Mutations in the p53 gene occur more
frequently in cardia cancers than in cancers from the lower
part of the stomach.40 41
Our findings suggest that multiple tumour suppressor
genes on chromosome 12 may be involved in the development
of some gastric cancers. We anticipate that the identification of
the specific genes involved will provide avenues for better
understanding of the molecular mechanisms of gastric
carcinogenesis.
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